Source link : https://www.newshealth.biz/health-news/injectable-anticoagulant-substantially-cuts-bleeding-risk-in-afib/
Novel agent abelacimab has potential to be a safer anticoagulant, according to the randomized AZALEA-TIMI 71 trial. The trial had been stopped early because of a surprisingly large reduction in bleeds with abelacimab. It remains to be seen whether abelacimab is clinically effective for stroke prevention in people with atrial fibrillation. For people with atrial […]
Author : News Health
Publish date : 2025-01-23 20:37:32
Copyright for syndicated content belongs to the linked Source.